167 related articles for article (PubMed ID: 10329458)
21. Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthase.
Valderas MW; Andi B; Barrow WW; Cook PF
Biochim Biophys Acta; 2008 May; 1780(5):848-53. PubMed ID: 18342015
[TBL] [Abstract][Full Text] [Related]
22. Dihydropteroate synthase based sensor for screening multi-sulfonamides residue and its comparison with broad-specific antibody based immunoassay by molecular modeling analysis.
Liang X; Li C; Zhu J; Song X; Yu W; Zhang J; Zhang S; Shen J; Wang Z
Anal Chim Acta; 2019 Mar; 1050():139-145. PubMed ID: 30661581
[TBL] [Abstract][Full Text] [Related]
23. Crystal structures of Burkholderia cenocepacia dihydropteroate synthase in the apo-form and complexed with the product 7,8-dihydropteroate.
Morgan RE; Batot GO; Dement JM; Rao VA; Eadsforth TC; Hunter WN
BMC Struct Biol; 2011 May; 11():21. PubMed ID: 21554707
[TBL] [Abstract][Full Text] [Related]
24. Large scale molecular dynamics simulation of native and mutant dihydropteroate synthase-sulphanilamide complexes suggests the molecular basis for dihydropteroate synthase drug resistance.
Giordanetto F; Fowler PW; Saqi M; Coveney PV
Philos Trans A Math Phys Eng Sci; 2005 Aug; 363(1833):2055-73. PubMed ID: 16099766
[TBL] [Abstract][Full Text] [Related]
25. A highly sensitive and class-specific fluorescence polarisation assay for sulphonamides based on dihydropteroate synthase.
Wang Z; Liang X; Wen K; Zhang S; Li C; Shen J
Biosens Bioelectron; 2015 Aug; 70():1-4. PubMed ID: 25775967
[TBL] [Abstract][Full Text] [Related]
26. Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum.
Wang P; Wang Q; Aspinall TV; Sims PF; Hyde JE
Mol Microbiol; 2004 Mar; 51(5):1425-38. PubMed ID: 14982635
[TBL] [Abstract][Full Text] [Related]
27. Additive effects of a two-amino-acid insertion and a single-amino-acid substitution in dihydropteroate synthase for the development of sulphonamide-resistant Neisseria meningitidis.
Qvarnström Y; Swedberg G
Microbiology (Reading); 2000 May; 146 ( Pt 5)():1151-1156. PubMed ID: 10832642
[TBL] [Abstract][Full Text] [Related]
28. Structural studies of pterin-based inhibitors of dihydropteroate synthase.
Hevener KE; Yun MK; Qi J; Kerr ID; Babaoglu K; Hurdle JG; Balakrishna K; White SW; Lee RE
J Med Chem; 2010 Jan; 53(1):166-77. PubMed ID: 19899766
[TBL] [Abstract][Full Text] [Related]
29. Probing the roles of non-homologous insertions in the N-terminal domain of Plasmodium falciparum hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase.
Rattanachuen W; Jönsson M; Swedberg G; Sirawaraporn W
Mol Biochem Parasitol; 2009 Dec; 168(2):135-42. PubMed ID: 19631695
[TBL] [Abstract][Full Text] [Related]
30. The kinetic mechanism of S. pneumoniae DNA ligase and inhibition by adenosine-based antibacterial compounds.
Jahić H; Liu CF; Thresher J; Livchak S; Wang H; Ehmann DE
Biochem Pharmacol; 2012 Sep; 84(5):654-60. PubMed ID: 22743594
[TBL] [Abstract][Full Text] [Related]
31. Mutations and horizontal transmission have contributed to sulfonamide resistance in Streptococcus pyogenes.
Jönsson M; Ström K; Swedberg G
Microb Drug Resist; 2003; 9(2):147-53. PubMed ID: 12820799
[TBL] [Abstract][Full Text] [Related]
32. Sulfonamide resistance: mechanisms and trends.
Sköld O
Drug Resist Updat; 2000 Jun; 3(3):155-160. PubMed ID: 11498380
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of bi-substrate state mimics of dihydropteroate synthase as potential inhibitors and molecular probes.
Qi J; Virga KG; Das S; Zhao Y; Yun MK; White SW; Lee RE
Bioorg Med Chem; 2011 Feb; 19(3):1298-305. PubMed ID: 21216602
[TBL] [Abstract][Full Text] [Related]
34. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis.
Aspinall TV; Joynson DH; Guy E; Hyde JE; Sims PF
J Infect Dis; 2002 Jun; 185(11):1637-43. PubMed ID: 12023770
[TBL] [Abstract][Full Text] [Related]
35. Kinetic and chemical mechanisms of the fabG-encoded Streptococcus pneumoniae beta-ketoacyl-ACP reductase.
Patel MP; Liu WS; West J; Tew D; Meek TD; Thrall SH
Biochemistry; 2005 Dec; 44(50):16753-65. PubMed ID: 16342966
[TBL] [Abstract][Full Text] [Related]
36. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.
Chakraborty S; Gruber T; Barry CE; Boshoff HI; Rhee KY
Science; 2013 Jan; 339(6115):88-91. PubMed ID: 23118010
[TBL] [Abstract][Full Text] [Related]
37. Genetic basis for sulfonamide resistance in Bacillus anthracis.
Valderas MW; Bourne PC; Barrow WW
Microb Drug Resist; 2007; 13(1):11-20. PubMed ID: 17536929
[TBL] [Abstract][Full Text] [Related]
38. Analysis of random mutations in Salmonella Gallinarum dihydropteroate synthase conferring sulfonamide resistance.
Duysak T; Jeong JH; Kim K; Kim JS; Choy HE
Arch Microbiol; 2023 Oct; 205(12):363. PubMed ID: 37906281
[TBL] [Abstract][Full Text] [Related]
39. Binding Isotope Effects for para-Aminobenzoic Acid with Dihydropteroate Synthase from Staphylococcus aureus and Plasmodium falciparum.
Stratton CF; Namanja-Magliano HA; Cameron SA; Schramm VL
ACS Chem Biol; 2015 Oct; 10(10):2182-6. PubMed ID: 26288086
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection.
Kovacs JA; Powell F; Voeller D; Allegra CJ
Antimicrob Agents Chemother; 1993 Jun; 37(6):1227-31. PubMed ID: 7687120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
